Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer

NCT01589094 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Gemcitabine and Cisplatin (DD GC)

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]